Skip to content
Triangle logo TriangleGet started
← Back to this collection

STATFACTS · dlbcl

Diffuse Large B-Cell Lymphoma (DLBCL)

Open original source → · Download preserved record

Source-level population statistics, not individual predictions. Different measures and subtypes are not interchangeable.

id
dlbcl
name
Diffuse Large B-Cell Lymphoma (DLBCL)
source title
Cancer Stat Facts: NHL — Diffuse Large B-Cell Lymphoma (DLBCL)
source
id
dlbcl
name
Diffuse Large B-Cell Lymphoma (DLBCL)
file
raw/dlbcl.html
sha256
1b0af27a7adea8008a3e91596892e3fe8c7814477b6d850a120339f615febbfa
bytes
74950
retrieved at
2026-09-09T23:18:22.588946+00:00
kind
cancer_or_subtype
historical survival
metric
relative_survival
horizon years
5
estimate type
observed_published_estimate
x axis
diagnosis_year
cohort
registry
SEER 8
diagnosis years
  1. 1975
  2. 2018
race
All races
sex
Both sexes
age range
Source null
age adjustment
Source null
source footnote
SEER 8 5-Year Relative Survival Percent from 1975–2018, All Races, Both Sexes. Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software.
stage
All stages
points
  1. diagnosis year
    1975
    percent
    36.05
  2. diagnosis year
    1976
    percent
    41.13
  3. diagnosis year
    1977
    percent
    38.87
  4. diagnosis year
    1978
    percent
    39.04
  5. diagnosis year
    1979
    percent
    38.21
  6. diagnosis year
    1980
    percent
    40.67
  7. diagnosis year
    1981
    percent
    42.13
  8. diagnosis year
    1982
    percent
    38.99
  9. diagnosis year
    1983
    percent
    46.17
  10. diagnosis year
    1984
    percent
    41.74
  11. diagnosis year
    1985
    percent
    46.81
  12. diagnosis year
    1986
    percent
    40.48
missing years
  1. diagnosis year
    2019
    status
    not_reported
    source value
    -
    modeled value present
    true
  2. diagnosis year
    2020
    status
    not_reported
    source value
    -
    modeled value present
    true
  3. diagnosis year
    2021
    status
    not_reported
    source value
    -
    modeled value present
    true
  4. diagnosis year
    2022
    status
    not_reported
    source value
    -
    modeled value present
    true
  5. diagnosis year
    2023
    status
    not_reported
    source value
    -
    modeled value present
    true
source table id
scrapeTable_01
confidence intervals
Source null
sample sizes
Source null
overall survival
metric
relative_survival
horizon years
5
percent
64.8
cohort
registry
SEER 21 (Excluding IL)
diagnosis years
  1. 2016
  2. 2022
race
All races
sex
Both sexes
age range
Source null
age adjustment
Source null
source footnote
Based on data from SEER 21 (Excluding IL) 2016–2022. Gray figures represent those who have died from diffuse large B-cell lymphoma. Green figures represent those who have survived 5 years or more.
stage
All stages
demographic scope source
Category survival-trend footnote; pooled box source footnote retained separately
source element
statBox
stage survival
metric
relative_survival
horizon years
5
cohort
registry
SEER 17
diagnosis years
  1. 2016
  2. 2022
race
All races
sex
Both sexes
age range
Source null
age adjustment
Source null
source footnote
SEER 17 2016–2022, All Races, Both Sexes by Ann Arbor Stage. Statistics by stage only include cases coded as Lymhpoma or Lymphoma-CLL/SLL in EOD 2018 schema definitions.
stage system
Ann Arbor Stage
points
  1. stage
    Stage I
    stage description
    Stage I Confined to Single Region
    cases percent
    20
    survival percent
    79.9
    source value
    79.9%
  2. stage
    Stage II
    stage description
    Stage II Involving Mulitple Regions
    cases percent
    19
    survival percent
    76
    source value
    76.0%
  3. stage
    Stage III
    stage description
    Stage III Spread to Both Sides of Diaphragm
    cases percent
    16
    survival percent
    67.5
    source value
    67.5%
  4. stage
    Stage IV
    stage description
    Stage IV Diffuse or Disseminated Involvement
    cases percent
    40
    survival percent
    56.3
    source value
    56.3%
  5. stage
    Unknown
    stage description
    Unknown Unstaged
    cases percent
    5
    survival percent
    54.6
    source value
    54.6%
source table id
scrapeTable_02
subtype survival
    additional survival tables
      availability
      historical survival
      available
      overall survival
      available
      stage survival
      available
      reuse
      public domain statement present
      true
      attribution
      National Cancer Institute, SEER Cancer Stat Facts
      limitations
      1. Published aggregate registry statistics; no individual-level records.
      2. Five-year relative survival is not overall survival, a treatment effect, or an individual prognosis.
      3. Year-of-diagnosis trends are not survival curves across follow-up time.
      4. Null age_range means no explicit age subgroup in the source; it does not mean age zero.
      5. No survival age adjustment is asserted unless explicitly documented.
      6. Do not join pooled current estimates onto annual historical trends: registry coverage and cohorts differ.

      Preserved source evidence · Not medical advice